The FDA approved Darzalex Faspro with Velcade, Revlimid and dexamethasone for newly diagnosed multiple myeloma ineligible for ...
A voice-activated device reduces mental distress while improving quality of life, diabetes self-care, and glycemic control.
Aclaris Therapeutics reported early study results showing its ATI-2138 drug drove rapid and lasting hair regrowth, ...
D-VRd is the only quadruplet regimen approved for patients with newly diagnosed multiple myeloma, irrespective of transplant ...
3hon MSN
When patients report symptoms, clinicians can judge cancer treatment side effects more consistently
A large multinational clinical trial has found that giving health care providers access to European Organization for Research ...
The trial will enrol up to 70 patients with refractory glaucoma and has a 12-month primary effectiveness endpoint.
Tirzepatide ( Mounjaro, Zepbound) users should never share KwikPens due to risk for transmission of blood-borne pathogens, ...
Huahui Health announced that China National Medical Products Administration (NMPA) has granted conditional approval to its ...
According to results from the IMerge trial, 2 39.8% of patients treated with imetelstat achieved 8 weeks of transfusion ...
Huahui Health announced that China's National Medical Products Administration (NMPA) has granted conditional approval to its ...
Nine-month findings show mean improvement in Composite Unified Huntington's Disease Rating Scale from baseline of +0.64 ...
Neurotech’s NTI164 is turning PANS from a mystery into measurable biology by resetting the immune pathways driving the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results